What is the exact dose of metoprolol (beta blocker) for intravenous (IV) push administration in supraventricular tachycardia (SVT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metoprolol IV Push Dosing for SVT

For supraventricular tachycardia (SVT), metoprolol should be administered intravenously at 5 mg over 1-2 minutes, which can be repeated at 5-minute intervals up to a maximum total dose of 15 mg. 1

Dosing Protocol

  • Initial dose: 5 mg IV push over 1-2 minutes
  • Wait 5-10 minutes to assess response
  • If inadequate response and no adverse effects: Administer additional 5 mg IV push
  • May repeat up to a total maximum dose of 15 mg (three 5 mg doses)
  • Monitor vital signs continuously during administration

Clinical Considerations

Patient Monitoring

  • Continuous ECG monitoring is mandatory during administration
  • Monitor blood pressure before each dose
  • Have resuscitation equipment immediately available

Contraindications

  • Severe bradycardia
  • Heart block greater than first degree
  • Cardiogenic shock
  • Decompensated heart failure
  • Hypotension (systolic BP <100 mmHg)

Potential Adverse Effects

  • Hypotension (most common side effect)
  • Bradycardia
  • Bronchospasm (particularly in patients with reactive airway disease)
  • Worsening heart failure in patients with ventricular dysfunction

Alternative Agents for SVT

If metoprolol is contraindicated or ineffective, consider:

  1. Adenosine: 6 mg rapid IV bolus, followed by 12 mg if needed (first-line for most SVTs)
  2. Diltiazem: 0.25 mg/kg IV over 2 minutes, followed by infusion at 5-15 mg/hour
  3. Verapamil: 5-10 mg IV over 2 minutes

Important Cautions

  • Never use in pre-excited atrial fibrillation or flutter (may accelerate ventricular response)
  • Avoid combining with other AV nodal blocking agents with longer half-lives
  • Use with extreme caution in patients with asthma or COPD
  • Hypotension may occur but is usually transient and manageable 2

Efficacy

Metoprolol has been shown to effectively reduce ventricular rate in 69-81% of patients with SVT, with rate reductions of 26-60 beats/minute in responders 2. The drug works by slowing conduction through the AV node and increasing AV nodal refractoriness 3.

For ongoing management after acute conversion, oral metoprolol may be considered at doses of 50-100 mg twice daily for prophylaxis against recurrent episodes 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.